Current and investigational medications for the treatment of sarcopenia.

Rolland, Yves; Dray, Cedric; Vellas, Bruno; Barreto, Philipe De Souto

Rolland, Yves; Dray, Cedric; Vellas, Bruno; Barreto, Philipe De Souto.

Afiliação

Rolland Y; Gérontopôle de Toulouse, IHU HealthAge, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, France; CERPOP UMR 1295, University of Toulouse III, Inserm, UPS, Toulouse, France. Electronic address: rolland.y@chu-toulouse.fr.
Dray C; Université de Toulouse III Université Paul Sabatier, Toulouse, France; Restore, a geroscience and rejuvenation research center, UMR 1301-Inserm, 5070-CNRS EFS, France.
Vellas B; Gérontopôle de Toulouse, IHU HealthAge, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, France; CERPOP UMR 1295, University of Toulouse III, Inserm, UPS, Toulouse, France.
Barreto PS; Gérontopôle de Toulouse, IHU HealthAge, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, France; CERPOP UMR 1295, University of Toulouse III, Inserm, UPS, Toulouse, France.

Metabolism ; 149: 155597, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37348598

Assuntos

Hormônio do Crescimento Humano; Sarcopenia; Masculino; Humanos; Feminino; Idoso; Sarcopenia/tratamento farmacológico; Antagonistas de Receptores de Angiotensina; Inibidores da Enzima Conversora de Angiotensina; Força Muscular

Palavras-chave

Aging; Drug; Muscle mass; Muscle strength; Physical performance; Prevention; Sarcopenia; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônio do Crescimento Humano / Sarcopenia Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google